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RESULTS
METHODS
CONCLUSIONS
Hypoaldosteronism (HA), a cause of hypovolemic hyponatremia (HN) with urinary(U) sodium(Na) loss, is often underdiagnosed. We studied the characteristics of 28 patients with an episode of HA-induced moderate/severe hyponatremia.
A single center, retrospective study of all 28 patients seen by Endocrinology at our general hospital between 2012-2015 with hypoaldosteronism-induced moderate/severe hyponatremia. All patients presented a Nadir serum Na (NSNa) <130 mmol/L (corrected for total proteins and glycemia), low yugular central venous pressure, low ocular pressure, with Addison's Disease ruled out (ACTH, cortisol and/or Synacthen test). In all cases, UNa>25 mmol/L, U osmolality(Osm)> Plasma(P) Osm, the Transtubular Potassium Gradient (TTKG) < 5. Group I (10/28) had risk factors for aldosterone deficit (heparin, ARBs, ACEi, aliskiren, NSAIDs, and/or tacrolimus), Group II (2/28) risk factors for mineralocorticoid resistance (obstructive uropathy, urinary infection, renal transplant, trimetroprim, and/or spironolactone), Group III (16/28): both. Na, Potassium (K) values in mmol/L, Osm mOsm/kg. Student's T-test, X 2 , Spearman´s Rho, Kruskal-Wallis, Mann-Whitney U. Na, K in mmol/L.
Hypoaldosteronism can induce marked hyponatremia. Most patients had risk factors for both inhibition of aldosterone secretion and mineralocorticoid resistance. Heparin and/or trimetoprim use was associated with lower serum sodium and serum osmolality levels. Patients with both high renin (>25 pg/ml) and low aldosterone (<100 pg/ml), all in Gr III, had significantly lower NSNa:113.33(4.04) than the rest: 123.19(4.2), p= 0.033.
